Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process.

Abstract:

BACKGROUND/AIM:Changes in epidermal growth factor receptor (EGFR) are commonly found in cancer progression, signaling a poor outcome in patients. In the present study, we aimed to investigate whether nimotuzumab could be of benefit for cholangiocarcinoma (CCA) treatment. MATERIALS AND METHODS:The expression of EGFR was explored using immunohistochemical staining in cases divided into groups with low and high expression. The effect of nimotuzumab on CCA cell growth, metastasis and the molecular mechanisms by which nimotuzumab inhibits CCA cell metastasis were evaluated. RESULTS:The expression of EGFR was high in 55% of patients with CCA. This was significantly correlated with a shorter survival of patients. CCA cells treated with nimotuzumab showed inhibited cell growth. Moreover, nimotuzumab inhibited CCA cell metastasis via induction of E-cadherin and suppression of zinc finger protein SNAI1 (SNAIL1), vimentin and matrix metalloproteinase 9 (MMP9) expression. CONCLUSION:Nimotuzumab appears to inhibit cell metastasis via suppression of the epithelial-mesenchymal transition process. Therefore, nimotuzumab should be considered as a potential therapeutic agent against CCA.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Padthaisong S,Thanee M,Techasen A,Namwat N,Yongvanit P,Liwatthakun A,Hankla K,Sangkhamanon S,Loilome W

doi

10.21873/anticanres.11729

subject

Has Abstract

pub_date

2017-07-01 00:00:00

pages

3591-3597

issue

7

eissn

0250-7005

issn

1791-7530

pii

37/7/3591

journal_volume

37

pub_type

杂志文章
  • HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence.

    abstract:AIM:The primary aim of the study was to assess the association between risk of recurrence and HER2 equivocal gene status through immunohistochemistry in patients with early breast cancer. PATIENTS AND METHODS:We retrospectively analyzed clinical and pathological data of 455 consecutive patients with early breast cance...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Criscitiello C,Bagnardi V,Viale G,Disalvatore D,Rotmensz N,Esposito A,Goldhirsch A,Curigliano G

    更新日期:2016-07-01 00:00:00

  • Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells.

    abstract:BACKGROUND:Phytoestrogens are known to prevent tumor induction. But their molecular mechanisms of action are largely unknown. This study aimed to examine the effect of genistein and quercetin on proliferation and apoptosis in HER2-expressing breast cancer cells. MATERIALS AND METHODS:The antiproliferative effects of p...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Seo HS,Choi HS,Choi HS,Choi YK,Um JY,Choi I,Shin YC,Ko SG

    更新日期:2011-10-01 00:00:00

  • Effects of short-term tamoxifen administration in patients with invasive cervical carcinoma.

    abstract::Cervical cancer is not considered a hormone-responsive tumor in spite of the presence of estrogen receptors (ER) and progesterone receptors (PgR) in some of them. Endocrine treatments have not achieved clinical responses, however, tamoxifen has been reported to induce PgR and to inhibit cell growth of many cervical ca...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Vargas Roig LM,Lotfi H,Olcese JE,Lo Castro G,Ciocca DR

    更新日期:1993-11-01 00:00:00

  • Comparison of the tumor inhibiting effects of three histamine H2-receptor antagonists.

    abstract::Three histamine H2-receptor antagonists, Cimetidine, Metiamide and Ranitidine, were tested for their inhibitory effect on two experimental bowel cancer models. In the first model mitotic rates were measured in dimethylhydrazine-induced tumors of rat colon and in the second model volumetric changes in human large bowel...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tutton PJ,Barkla DH

    更新日期:1983-01-01 00:00:00

  • The anti-metastatic effect of intravenously-inoculated BCG on prostate tumor cells.

    abstract::The complication of metastasis from the primary tumor site to the distant organ is difficult to control. Tumor cells usually spread through the vascular system: lymphatics and/or blood; or by direct extension into adjacent sites. Transplantable prostate adenocarcinoma (PA-III) cells in L-W rats produces a tumor in the...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pollard M,Luckert PH

    更新日期:1993-05-01 00:00:00

  • Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.

    abstract:BACKGROUND:The transforming growth factor beta (TGF-beta) superfamily regulates cell growth in various cells. Previous studies have shown that altered expression of TGF-beta receptors, Smad2 and Smad4, as mediators of TGF-beta superfamily signaling, contributes to tumor progression in esophageal squamous cell carcinoma...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Osawa H,Nakajima M,Kato H,Fukuchi M,Kuwano H

    更新日期:2004-11-01 00:00:00

  • LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ.

    abstract::The expression of a cell surface-associated sialoglycoprotein (LEA.135), which has been shown to be significantly associated with decreased incidence of recurrence and increased overall survival of patients with primary invasive breast carcinoma, was evaluated in a retrospective study to identify subsets of patients w...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Baltayan A,Naritoku WY,Chaiwun B,Tsao-Wei DD,Groshen S,Hern RA,Gusterson BA,Taylor CR,Imam SA

    更新日期:2002-09-01 00:00:00

  • Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer.

    abstract:BACKGROUND:We report the prognostic significance of peripheral and tumor-infiltrating Th1, Th2, Tc1 and Tc2 cells in lung cancer patients. MATERIALS AND METHODS:We evaluated the rates of interferon (IFN)-gamma+/CD4+ cells (Th1), interleukin (IL)-4+ /CD4+ cells (Th2), IFN-gamma+/CD8+ cells (Tc1), IL-4+ /CD8+ cells (Tc2...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ito N,Suzuki Y,Taniguchi Y,Ishiguro K,Nakamura H,Ohgi S

    更新日期:2005-05-01 00:00:00

  • New in vitro line from a human (B) non-Hodgkin lymphoma.

    abstract::An in vitro cell line (HT 58) has been established from a human (B) NHL xenograft. The lymphoma cells in culture retained their lymphoblastic appearance, DNA-content, IgM/lambda monoclonality and many immunophenotypic markers. The clonal chromosomal abnormalities involved the chromosomes 1, 2, 3 and 14. The cells expr...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kopper L,Bankfalvi A,Mihalik R,Nagy P,Fulop C,Sarmay G

    更新日期:1991-07-01 00:00:00

  • Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells.

    abstract::Glioblastoma multiforme (GBM) is the most aggressive intracranial tumor characterized with infaust prognosis. Despite advances in neurosurgical and radiotherapeutic techniques and chemotherapy, the median overall survival ranges between 12-15 months from diagnosis. The main cause of treatment failure is considered the...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11422

    authors: Ondracek J,Fadrus P,Sana J,Besse A,Loja T,Vecera M,Radova L,Smrcka M,Slampa P,Slaby O

    更新日期:2017-03-01 00:00:00

  • Novel treatment strategies for cancer and their tumor-targeting approaches using antibodies against tumor-associated antigens.

    abstract::Novel treatment strategies for cancer that are based on a more detailed understanding over the tumor biology are based on the latest new technology and are expected to improve the current treatment outcome for patients with cancer. However, many of these strategies still have one common and critical problem, being the...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Kuroki M,Shirasu N

    更新日期:2014-08-01 00:00:00

  • Differential expression of p-mTOR in cutaneous basal and squamous cell carcinomas likely explains their different response to mTOR inhibitors in organ-transplant recipients.

    abstract:BACKGROUND:Mammalian Target of Rapamycin (mTOR) inhibitors, such as sirolimus and everolimus, have been shown to reduce cutaneous carcinogenesis in organ-transplant recipients requiring for immunosuppressive treatment to prevent from allograft rejection. Clinical observations suggest that cutaneous squamous cell carcin...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Karayannopoulou G,Euvrard S,Kanitakis J

    更新日期:2013-09-01 00:00:00

  • Adjuvant treatment for breast cancer in the elderly.

    abstract::Eighty one patients with breast cancer stages I, II and III (T3a) were given adjuvant treatment with tamoxifen (Nolvadex), chemotherapy, or both. Most patients had estrogen and progesterone receptors measurement. Twenty one (63.6%) patients of the tamoxifen group were node positive, all 25 (100%) of the chemotherapy p...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Marchei P,Bianco V,Pignatelli E,Chiodini S,Santini D,Carico E,Marchei M,Vecchione A

    更新日期:1996-03-01 00:00:00

  • Invading basal cell carcinoma of the jaw: an under-evaluated complex entity.

    abstract::Basal cell carcinoma (BCC) is a locally invasive neoplasm, rarely metastatic, yet capable of significant local destruction and disfigurement. Invasion into the bone is uncommon and only a few cases of invasion into facial bones, but never to the mandible or maxilla, have been described. We report three patients with B...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nagler RM,Laufer D

    更新日期:2001-01-01 00:00:00

  • Cyclosporin A Reversed Chemoresistance of a Patient with Pure Red Cell Aplasia Secondary to Thymoma.

    abstract:CASE REPORT:This case study reports on a patient who relapsed with thymoma (mixed type) nine years after tumor resection. After four courses of rescue chemotherapy (docetaxel and cisplatinum), the patient was further diagnosed with pure red cell aplasia. It was noticed that cyclosporin A (CsA), which was administered t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11861

    authors: Li P,Du F,Gong Z,Hu B,Chi C,Chu H,Chen J

    更新日期:2017-08-01 00:00:00

  • COX-2 expression in rectal carcinoma: immunohistochemical pattern and clinical outcome.

    abstract:BACKGROUND:Increasing evidence suggests that COX-2 promotes carcinogenesis but it is controversial as to whether COX-2 expression is a prognostic factor for rectal carcinoma. MATERIALS AND METHODS:Data of 62 consecutive patients with rectal carcinoma in UICC-stages I-III, which were curatively resected between 1995 an...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Petersen S,Haroske G,Hellmich G,Ludwig K,Petersen C,Eicheler W

    更新日期:2002-03-01 00:00:00

  • Left Ventricular Speckle Tracking Echocardiography Changes Among Early-stage Breast Cancer Patients Three Years After Radiotherapy.

    abstract:BACKGROUND/AIM:Chest radiotherapy (RT) doubles late cardiac mortality. This study aimed to evaluate the evolution of cardiac changes in speckle tracking echocardiography during a three-year follow-up. MATERIALS AND METHODS:This prospective study included 81 chemotherapy-naïve early-stage breast cancer patients who wer...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13584

    authors: Tuohinen SS,Skytta T,Huhtala H,Virtanen V,Kellokumpu-Lehtinen PL,Raatikainen P

    更新日期:2019-08-01 00:00:00

  • Docetaxel, estramustine and prednisone for hormone-refractory prostate cancer: a single-center experience.

    abstract:BACKGROUND:The results of chemotherapy in patients with advanced, hormone-refractory prostate cancer (HRPC) have been disappointing. Mitoxantrone has been used in the past for palliation, but it does not prolong survival. It was recently demonstrated that docetaxel is able to improve median survival as compared to mito...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Boehmer A,Anastasiadis AG,Feyerabend S,Nagele U,Kuczyk M,Schilling D,Corvin S,Merseburger AS,Stenzl A

    更新日期:2005-11-01 00:00:00

  • F16, a fraction from Eurycoma longifolia jack extract, induces apoptosis via a caspase-9-independent manner in MCF-7 cells.

    abstract::F16 is a plant-derived pharmacologically active fraction extracted from Eurycoma longifolia Jack. Previously, we have reported that F16 inhibited the proliferation of MCF-7 human breast cancer cells by inducing apoptotic cell death while having some degree of cytoselectivity on a normal human breast cell line, MCF-10A...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tee TT,Cheah YH,Hawariah LP

    更新日期:2007-09-01 00:00:00

  • Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.

    abstract::Previous reports have shown that one copy of the chromosome 17 was frequently lost in human ovarian cancers (1). The position of the allelic deletion has not been mapped and involvement of p53 gene has not been determined. In this study, we have shown that in human ovarian carcinoma, the commonest region of allelic lo...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tsao SW,Mok CH,Oike K,Muto M,Goodman HM,Sheets EE,Berkowitz RS,Knapp RC,Lau CC

    更新日期:1991-11-01 00:00:00

  • Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene.

    abstract:BACKGROUND:Pemetrexed and erlotinib represent different agents commonly used for the second-line treatment of patients with advanced-stage non-small cell lung cancer (NSCLC). PATIENTS AND METHODS:We analyzed data of 137 patients with advanced-stage non-squamous NSCLC treated with pemetrexed or erlotinib in the second ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fiala O,Pesek M,Finek J,Svaton M,Minarik M,Benesova L,Bortlicek Z,Kucera R,Topolcan O

    更新日期:2016-01-01 00:00:00

  • A case of gastric adenocarcinoma associated with giant-cell phlebitis.

    abstract::A 60-year-old male patient with advanced gastric adenocarcinoma was treated by subtotal gastrectomy with dissection of the regional lymph nodes. Microscopic examination of the tumour revealed tubular adenocarcinoma which invaded the muscularis propria. There was no evidence of metastatic carcinoma in the dissected lym...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Caruso RA,Parisi A,Valerio F,Napoli P,Parisi G

    更新日期:2003-09-01 00:00:00

  • Triptorelin (D-Trp-6-LHRH) in combination with carboplatin-containing polychemotherapy for advanced ovarian cancer: a pilot study.

    abstract::In experimental and clinical phase II trials GnRH agonists were shown to possess antitumor activity in ovarian cancer. The outcome of prostatic cancer was also improved experimentally by a combination of cytostatic chemotherapy and GnRH analogs. Encouraged by these results, we administered micro-encapsulated triptorel...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Medl M,Peters-Engel C,Fuchs G,Leodolter S

    更新日期:1993-11-01 00:00:00

  • Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) in human hepatocellular carcinoma.

    abstract::One of the major obstacles in the treatment of hepatocellular carcinoma (HCC) is the intrinsic/acquired resistance to cisplatin-based chemotherapy. Copper-transporting P-type adenosine triphosphate (ATP7B) has been reported to be associated with cisplatin resistance in vitro. However, the expression of ATP7B has not p...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sugeno H,Takebayashi Y,Higashimoto M,Ogura Y,Shibukawa G,Kanzaki A,Terada K,Sugiyama T,Watanabe K,Katoh R,Nitta Y,Fukushima T,Koyama Y,Inoue N,Sekikawa K,Ogawa K,Sato Y,Takenoshita S

    更新日期:2004-03-01 00:00:00

  • Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients.

    abstract::In this immunohistochemical study we investigated the expression of Bcl-2 and Bax apoptosis related proteins in node-negative breast carcinomas. The results were correlated with the recurrence rate of the patients. In order to avoid the influence of the most important tumor prognostic parameters we selected two groups...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kapranos N,Karaiosifidi H,Valavanis C,Kouri E,Vasilaros S

    更新日期:1997-07-01 00:00:00

  • Cellular oncogenes, mutations and cancer.

    abstract::The multistep nature of cancer suggested from chemical carcinogenesis studies, epidemiological data and cell culture experiments could be explained by the occurrence of somatic mutations resulting in inappropriate expression of normal cellular sequences which have an intrinsic potential of becoming cancer genes. The d...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Spandidos DA

    更新日期:1983-03-01 00:00:00

  • Adenocarcinoma production in rats administered 1,2-dimethylhydrazine and fed iron salt and guar gum diets.

    abstract::Iron salts supplemented in a basal ratio, were fed to young Sprague-Dawley male rats for prolonged periods and the frequency of colonic adenocarcinomas induced by repeated s.c. injection of 1,2-dimethylhydrazine (DMH) at unit base doses of 9.0 mg/kg, ascertained and compared with the respective controls. In a series e...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gershbein LL,Rezai VK,Amir-Mokri E,Rao KC

    更新日期:1993-11-01 00:00:00

  • Long-term Oncologic Outcomes of Robotic-assisted Radical Prostatectomy by a Single Surgeon.

    abstract:AIM:The aim of the study was to evaluate the long-term oncology outcomes of prostate cancer patients receiving robotic-assisted radical prostatectomy (RARP). PATIENTS AND METHODS:We retrospectively evaluated 111 patients with clinically-localized prostate cancer receiving RARP with a mean follow-up of 103.43 months. ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11803

    authors: Hung SC,Yang CK,Cheng CL,Ou YC

    更新日期:2017-08-01 00:00:00

  • Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin.

    abstract:BACKGROUND:Dehydroepiandrosterone (DHEA) and its analogs have potent chemoprotective actions in mouse skin tumorigenesis models. To assess this association in humans, we investigated the relationship of prediagnostic serum concentrations of DHEA and dehydroepiandrosterone sulfate (DHEAS) to the subsequent risk of devel...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Alberg AJ,Gordon GB,Genkinger JM,Hoffman SC,Selvin E,Comstock GW,Helzlsouer KJ

    更新日期:2001-11-01 00:00:00

  • Adverse Prognostic Factors of Advanced Esophageal Cancer in Patients Undergoing Induction Therapy with Docetaxel, Cisplatin and 5-Fluorouracil.

    abstract:BACKGROUND/AIM:The purpose of this study was to identify adverse prognostic factors for patients with advanced esophageal cancer undergoing chemotherapy with docetaxel, cisplatin and 5-fluorouracil (DCF). PATIENTS AND METHODS:The study cohort comprised of 45 patients with advanced esophageal cancer who underwent induc...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12302

    authors: Nakajima M,Muroi H,Kikuchi M,Takahashi M,Ihara K,Shida Y,Kurayama E,Ogata H,Yamaguchi S,Sasaki K,Sakai M,Sohda M,Miyazaki T,Kuwano H,Kato H

    更新日期:2018-02-01 00:00:00